AJA Pharma Co. Ltd, subsidiary of Saudi Chemical Company, signed an agreement with global pharmaceutical firm Novartis to manufacture pharmaceutical products for the treatment of diabetes and blood pressure in the Kingdom, Saudi Press Agency (SPA) reported.
Under the deal, an investment of SAR 50 million will go into a production line at AJA’s Hail plant.
The expected value of the nationally manufactured drugs amounts to over SAR 1 billion within the next five years.
The project will provide more than 30 new job opportunities for Saudis in the pharmaceutical field during the first year.
AJA has built a pharmaceutical plant in Hail over a 120,000 square-meter land, where it launched trial operations recently.
Comments
{{DisplayName}}
{{ElapsedTime}}